Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways

Retraction of ‘Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways’ by Hongling Yang et al., RSC Adv., 2018, 8, 21816–21822, DOI: 10.1039/C8RA01674G.

Detalles Bibliográficos
Autor principal: Fisher, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694327/
https://www.ncbi.nlm.nih.gov/pubmed/35426982
http://dx.doi.org/10.1039/d1ra90018h
_version_ 1784619329859354624
author Fisher, Laura
author_facet Fisher, Laura
author_sort Fisher, Laura
collection PubMed
description Retraction of ‘Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways’ by Hongling Yang et al., RSC Adv., 2018, 8, 21816–21822, DOI: 10.1039/C8RA01674G.
format Online
Article
Text
id pubmed-8694327
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-86943272022-04-13 Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways Fisher, Laura RSC Adv Chemistry Retraction of ‘Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways’ by Hongling Yang et al., RSC Adv., 2018, 8, 21816–21822, DOI: 10.1039/C8RA01674G. The Royal Society of Chemistry 2021-01-20 /pmc/articles/PMC8694327/ /pubmed/35426982 http://dx.doi.org/10.1039/d1ra90018h Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Fisher, Laura
Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways
title Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways
title_full Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways
title_fullStr Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways
title_full_unstemmed Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways
title_short Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways
title_sort retraction: ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating mapk pathways
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694327/
https://www.ncbi.nlm.nih.gov/pubmed/35426982
http://dx.doi.org/10.1039/d1ra90018h
work_keys_str_mv AT fisherlaura retractionligustrazineattenuatesrenaldamagebyinhibitingendoplasmicreticulumstressindiabeticnephropathybyinactivatingmapkpathways

Ejemplares similares